Evidence map›Paper›PMID 36176003›Full record

ArticleTrials2022

Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.

Dina H Griauzde, Alison O'Brien, William S Yancy, Caroline R Richardson, Jamie Krinock, Melissa DeJonckheere, Deanna J M Isaman, Kaitlyn Vanias, Samuel Shopinski, Laura R Saslow

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05235425 (Testing a Very Low-carbohydrate Diet Version of the Diabetes Prevention Program to Reduce Risk Factors for Type 2 Diabetes), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05235425 nacompletednot on this map

Testing a Very Low-carbohydrate Diet Version of the Diabetes Prevention Program to Reduce Risk Factors for Type 2 Diabetes: The LEAP (Lifestyle Education About Prediabetes) Study

TypeinterventionalSponsorUniversity of MichiganRan2022 to 2025Enrolled304ConditionsPreDiabetesArmsStandard NDPP, Very low-carbohydrate diet
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dina H GriauzdeDepartment of Internal Medicine, University of Michigan Medical School, 2800 Plymouth Road, Building 16, Room 16-371C, Ann Arbor, MI, 48109-2800, USA. dhafez@med.umich.edu.ORCID http://orcid.org/0000-0002-2260-0299
Alison O'BrienDepartment of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, MI, USA.
William S YancyDepartment of Medicine, Duke University School of Medicine, Durham, NC, USA.
Caroline R RichardsonUniversity of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.
Jamie KrinockDepartment of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, MI, USA.
Melissa DeJonckheereUniversity of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.
Deanna J M IsamanDepartment of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, MI, USA.
Kaitlyn VaniasUniversity of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Samuel ShopinskiNational Kidney Foundation of Michigan, Ann Arbor, MI, USA.
Laura R SaslowUniversity of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Testing a very low-carbohydrate diet version of the Diabetes Prevention Program to reduce risk factors for type 2 diabetesR01DK125792 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SASLOW, LAURA · 2021 to 2025
$2.5M
A multilevel intervention to support weight loss among individuals with prediabetes in primary care settingsK23DK123416 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRIAUZDE, DINA HAFEZ · 2020 to 2024
$962k
NIDDK NIH HHS K23 DK123416NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R01 DK125792
6 · The paper itself

Abstract

backgroundThe Center for Disease Control and Prevention's National Diabetes Prevention Program (NDPP) aims to help individuals with prediabetes avoid progression to type 2 diabetes mellitus (T2DM) through weight loss. Specifically, the NDPP teaches individuals to follow a low-fat, calorie-restricted diet and to engage in regular physical activity to achieve ≥ 5% body weight loss. Most NDPP participants, however, do not achieve this weight loss goal, and glycemic control remains largely unchanged. One promising opportunity to augment the NDPP's weight loss and glycemic effectiveness may be to teach participants to follow a very low-carbohydrate diet (VLCD), which can directly reduce post-prandial glycemia and facilitate weight loss by reducing circulating insulin and enabling lipolysis. To date, there have been no high-quality, randomized controlled trials to test whether a VLCD can prevent progression to T2DM among individuals with prediabetes. The aim of this study is to test the effectiveness of a VLCD version the NDPP (VLC-NDPP) versus the standard NDPP. We hypothesize the VLC-NDPP will demonstrate greater improvements in weight loss and glycemic control.

methodsWe propose to conduct a 12-month, 1:1, randomized controlled trial that will assign 300 adults with overweight or obesity and prediabetes to either the NDPP or VLC-NDPP. The primary outcome will be glycemic control as measured by change in hemoglobin A1c (HbA1c) from baseline to 12 months. Secondary outcomes will include percent body weight change and changes in glycemic variability, inflammatory markers, lipids, and interim HbA1c. We will evaluate progression to T2DM and initiation of anti-hyperglycemic agents. We will conduct qualitative interviews among a purposive sample of participants to explore barriers to and facilitators of dietary adherence. The principal quantitative analysis will be intent-to-treat using hierarchical linear mixed effects models to assess differences over time. DISCUSSION: The NDPP is the dominant public health strategy for T2DM prevention. Changing the program's dietary advice to include a carbohydrate-restricted eating pattern as an alternative option may enhance the program's effectiveness. If the VLC-NDPP shows promise, this trial would be a precursor to a multi-site trial with incident T2DM as the primary outcome.

trial registrationNCT05235425. Registered February 11, 2022.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateAdultBlood GlucoseGlycated HemoglobinHumansHypoglycemic AgentsInsulinLife StyleLipidsNitro CompoundsPropiophenonesRandomized Controlled Trials as TopicWeight Loss4-nitro-3-dimethylaminopropiophenoneBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinLipidsNitro CompoundsPropiophenonesDiabetes Prevention ProgramDietary carbohydrate restrictionPrediabetesPreventionType 2 diabetesVery low-carbohydrate diet

Identifiers

PMID36176003
PMCPMC9524018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.